What does “peptide care” actually mean?

A peptide is a small chain of protein building blocks.

Peptides are small chains made from protein building blocks; insulin is a familiar example.

The name does not settle whether a product is approved, lawful or well studied as of September 26, 2026.

Think of “peptide” as the broad heading. Ask for the name underneath it.

Approval belongs to a particular medicine.

FDA, short for Food and Drug Administration, reviews medicines for approval. An approval covers a particular product and the uses listed on its label.

As of September 26, 2026, FDA-approved diabetes or weight-care products include semaglutide (Wegovy and Ozempic) and tirzepatide (Zepbound and Mounjaro).

Ozempic and Mounjaro treat type 2 diabetes; weight loss and keeping lost weight off are uses of Wegovy and Zepbound. These products also have some other approved uses.

A pharmacy-made version containing semaglutide or tirzepatide does not share the branded product’s FDA approval. An approved product’s label also does not cover every possible use.

Ask which product is being discussed and what its label says it is for.

Made to order is a different route.

Compounding is the preparation of medicine by a doctor or pharmacist for an individual patient’s needs.

As of September 26, 2026, compounded medicines lack FDA approval and its review before they reach patients.

FDA says a custom preparation can meet a medical need that an approved product does not address.

A research label is another matter.

As of September 26, 2026, FDA urges people to avoid unapproved weight medicines marketed for research: their quality is not known, and they could harm patients.

BPC-157 is the name of a peptide sold online. FDA records checked September 26, 2026, showed no application for it and no approved US medicine containing it.

That finding means no application was found in those records; it does not mean FDA rejected an application.

Lack of approval and permission to make a medicine to order are separate questions. The ingredients must also meet the rules for compounding.

For BPC-157, FDA’s July 2026 documents found no official drug-ingredient standard and no use as an ingredient in an approved medicine. It was also absent from the official list of ingredients allowed for patient-specific compounding.

Those findings do not support a claim that a prescription alone makes pharmacy compounding of BPC-157 lawful.

Ask the person treating you: What would this medicine treat? Is this exact product approved? If it is made to order, which rules allow its ingredients?

FDA advises you to avoid unapproved weight medicines whose labels say “not for human consumption” or “for research purposes”.